Search
for
Sort by
Research 31–60 of 1000+
- Three orphans one should know: red scalp, red ear and red scrotum syndrome
- Cutaneous drug reactions
- Cyclooxygenases in the skin: pharmacological and toxicological implications
- Hair and nail involvement in lupus erythematosus
- Alopecia areata – Current understanding and management
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Alopecia areata: Treatment options
- SP0227 Case 1 Presentation: Arthritis, Lupus and More. Rhupus or Polyautoimmunity?
- Central centrifugal cicatricial alopecia amalgamated with alopecia areata: immunologic findings
- Drug safety evaluation of exemestane
- New Nonsteroidal Molecules as Blockers of the Steroidogenic Pathway
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
- Search for New antineoplastic agents based on structural modifications of steroidal 5α-reductase, 17β-hydroxysteroid dehydrogenase, and 17α-hydroxylase/17,20-lyase inhibitors
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- The connection of 5-alpha reductase inhibitors to the development of depression
- Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Cutaneous Toxicities From Transplantation-Related Medications
- Alopecia areata
- Glabellar clinical and trichoscopic findings in patients with frontal fibrosing alopecia
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Frontal fibrosing alopecia
- Cutaneous lupus erythematosus: clinico-pathologic correlation